Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial to Reduce Cardiovascular Events With Aranesp® Therapy

NCT00093015 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00093015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00093015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial to Reduce Cardiovascular Events With Aranesp® Therapy
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2004
Completion date
July 1, 2009
Enrollment
4,038 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, diabetes mellitus, kidney disease